ITRM960827A0 - Medicamento per il trattamento terapeutico della maculopatia legata all'eta', della maculopatia non legata all'eta' e per la profilassi - Google Patents

Medicamento per il trattamento terapeutico della maculopatia legata all'eta', della maculopatia non legata all'eta' e per la profilassi

Info

Publication number
ITRM960827A0
ITRM960827A0 IT96RM000827A ITRM960827A ITRM960827A0 IT RM960827 A0 ITRM960827 A0 IT RM960827A0 IT 96RM000827 A IT96RM000827 A IT 96RM000827A IT RM960827 A ITRM960827 A IT RM960827A IT RM960827 A0 ITRM960827 A0 IT RM960827A0
Authority
IT
Italy
Prior art keywords
age
related maculopathy
prophylaxis
therapeutic treatment
medicinal product
Prior art date
Application number
IT96RM000827A
Other languages
English (en)
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of ITRM960827A0 publication Critical patent/ITRM960827A0/it
Priority to IT96RM000827A priority Critical patent/IT1288399B1/it
Priority to EP97120139A priority patent/EP0848952A1/en
Priority to US08/969,939 priority patent/US5883127A/en
Priority to MXPA/A/1997/009299A priority patent/MXPA97009299A/xx
Priority to JP9331554A priority patent/JPH10167963A/ja
Priority to ZA9710812A priority patent/ZA9710812B/xx
Priority to KR1019970065419A priority patent/KR19980063712A/ko
Priority to CA002223349A priority patent/CA2223349A1/en
Publication of ITRM960827A1 publication Critical patent/ITRM960827A1/it
Application granted granted Critical
Publication of IT1288399B1 publication Critical patent/IT1288399B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IT96RM000827A 1996-12-03 1996-12-03 Medicamento per il trattamento terapeutico della maculopatia legata all'eta', della maculopatia non legata all'eta' e per la profilassi IT1288399B1 (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IT96RM000827A IT1288399B1 (it) 1996-12-03 1996-12-03 Medicamento per il trattamento terapeutico della maculopatia legata all'eta', della maculopatia non legata all'eta' e per la profilassi
EP97120139A EP0848952A1 (en) 1996-12-03 1997-11-18 Use of lower alkanoyl l-carnitines to produce a medicament suitable for the therapeutic treatment of retinopathies
US08/969,939 US5883127A (en) 1996-12-03 1997-11-25 Use of lower alkanoyl L-carnitines to produce a medicament suitable for the therapeutic treatment of retinopathies
MXPA/A/1997/009299A MXPA97009299A (en) 1996-12-03 1997-12-01 Use of lower alcanylene l-carnitins to produce appropriate medication for the therapeutic treatment of retinopat
JP9331554A JPH10167963A (ja) 1996-12-03 1997-12-02 低級アルカノイルｌ−カルニチンを含有する網膜症治療用製剤
ZA9710812A ZA9710812B (en) 1996-12-03 1997-12-02 Use of lower alkanoyl l-carnitines to produce a medicament suitable for the therapeutic treatment of retinopathies
KR1019970065419A KR19980063712A (ko) 1996-12-03 1997-12-02 망막증의 치료에 유용한 저급 알카노일 ｌ-카르니틴
CA002223349A CA2223349A1 (en) 1996-12-03 1997-12-03 Use of lower alkanoyl l-carnitines to produce a medicament suitable for the therapeutic treatment of retinopathies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96RM000827A IT1288399B1 (it) 1996-12-03 1996-12-03 Medicamento per il trattamento terapeutico della maculopatia legata all'eta', della maculopatia non legata all'eta' e per la profilassi

Publications (3)

Publication Number Publication Date
ITRM960827A0 true ITRM960827A0 (it) 1996-12-03
ITRM960827A1 ITRM960827A1 (it) 1998-06-03
IT1288399B1 IT1288399B1 (it) 1998-09-22

Family

ID=11404565

Family Applications (1)

Application Number Title Priority Date Filing Date
IT96RM000827A IT1288399B1 (it) 1996-12-03 1996-12-03 Medicamento per il trattamento terapeutico della maculopatia legata all'eta', della maculopatia non legata all'eta' e per la profilassi

Country Status (7)

Country Link
US (1) US5883127A (it)
EP (1) EP0848952A1 (it)
JP (1) JPH10167963A (it)
KR (1) KR19980063712A (it)
CA (1) CA2223349A1 (it)
IT (1) IT1288399B1 (it)
ZA (1) ZA9710812B (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19718826A1 (de) * 1997-05-05 1998-11-12 Marion S Dr Eckmiller Verwendung biologisch aktiver Wirkstoffe zum Beeinflussen des Extrazellulär-Raumes von Sinneszellen und Verfahren zur Wirkstoff-Administrationssteuerung
ES2210705T5 (es) 1998-03-19 2011-02-15 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Composición combinada que comprende una l-carnitina o una alcanoil-l-carnitina, un glucosaminoglucano y/o un constituyente del mismo.
ITRM20020492A1 (it) * 2002-10-01 2004-04-02 Sigma Tau Ind Farmaceuti Uso della propionil l-carnitina per la preparazione di un medicamento per il trattamento del glaucoma.
US20060043155A1 (en) * 2004-08-24 2006-03-02 Jeff Lovin Method and system of friction welding
US8569367B2 (en) 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
EP2363126A1 (en) 2010-03-04 2011-09-07 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Composition comprising as active ingredient L-carnitine in combination with hydroxykynurenine-O-beta-DL-glucoside, for the prevention and/or treatment of pathologies of the eye due to ultraviolet radiation
EP2642991A1 (en) 2010-11-22 2013-10-02 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Therapeutical method for the treatment of the leber optic
US9907826B2 (en) 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
EP2783695A1 (en) 2013-03-28 2014-10-01 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Physiological supplement or medicament for ophthalmic use containing L-carnitine or alkanoyl L-carnitines in combination with eledoisin

Also Published As

Publication number Publication date
US5883127A (en) 1999-03-16
CA2223349A1 (en) 1998-06-03
ITRM960827A1 (it) 1998-06-03
ZA9710812B (en) 1998-07-01
KR19980063712A (ko) 1998-10-07
JPH10167963A (ja) 1998-06-23
MX9709299A (es) 1998-10-31
IT1288399B1 (it) 1998-09-22
EP0848952A1 (en) 1998-06-24

Similar Documents

Publication Publication Date Title
IL121170A0 (en) Compositions for the treatment of dermatological disorders
UA27911C2 (uk) Засіб для лікування або запобігання фізіологічних розладів, які викликані надлишком тахікініну
KR920701466A (ko) 면역조절 장애 치료를 위한 제약학적 생성물
IL127714A0 (en) Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of manic depressive bipolar disorders
ITBO920277A1 (it) Endoprotesi per osteosintesi del femore prossimale
HUP9904317A3 (en) Use of 1-hydroxy-2-pyridones for producing pharmaceutical compositions suitable for the treatment of skin diseases
ITRM960827A0 (it) Medicamento per il trattamento terapeutico della maculopatia legata all'eta', della maculopatia non legata all'eta' e per la profilassi
ITMI910456A0 (it) Composizione farmaceutica per il trattamento della cataratta
IT1270905B (it) Composizioni farmaceutiche contenenti n-acetilcarnosina per il trattamento della cataratta
ITMI910381A0 (it) Medicamento per il trattamento della dermatite
NO982562D0 (no) Sammensetning for behandling av smerte
ITRM940806A0 (it) Preparato per il trattamento dell'obesita'
ZA944671B (en) Medicaments for the treatment of inflammatory diseases
FI933872A0 (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 1,3,4-bensotriazepin-5(4h)-on-derivat
HUP0000570A3 (en) Use of 17 alpha-dihydroequilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states
ZA97253B (en) Topical compositions for the treatment of skin diseases
EP0579077A3 (en) 1,3,4-thiadiazinones for the treatment of cardiovascular diseases
ZA925983B (en) Pharmaceutical compositions for the treatment of skin disorders
GC0000176A (en) Pharmaceutical combination preparations for the treatment of cardiac disorders
HUP0000476A3 (en) Use of 17 betha-dihydroequilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states
ZA921101B (en) Use of tetra: Hydro-thieno-pyrido-indole derivatives for the prepartion of a medicine for the treatment of skin disorders.
GB9413939D0 (en) Pharmaceutical composition for the treatment of chronic skin ulcers
ITMI931174A0 (it) Composizioni farmaceutiche per la cura della talassemia
IL106917A0 (en) Compositions for the treatment of skin disorders
GB8922012D0 (en) Composition for treatment of respiratory ailments

Legal Events

Date Code Title Description
0001 Granted